Jeff Smith

Affiliations: 
University of Iowa, Iowa City, IA 
Google:
"Jeff Smith"

Parents

Sign in to add mentor
Richard Lemen fellowship/program director 1985-1988 University of Arizona
Wayne Morgan fellowship/program director 1985-1988 University of Arizona

Children

Sign in to add trainee
Matthew C. Cecil fellowship/program director 2000 The University of Iowa
Jane S. McConnell fellowship/program director 2000 The University of Iowa
Ki-Yul Uhm fellowship/program director 2000 The University of Iowa
Eliot M. Blake fellowship/program director 2002 The University of Iowa
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Ogasawara K, Dodds M, Mack T, et al. (2021) Correction to: Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma. Clinical Pharmacokinetics
Ogasawara K, Dodds M, Mack T, et al. (2021) Population Cellular Kinetics of Lisocabtagene Maraleucel, an Autologous CD19-Directed Chimeric Antigen Receptor T-Cell Product, in Patients with Relapsed/Refractory Large B-Cell Lymphoma. Clinical Pharmacokinetics
Zekonyte U, Bacman SR, Smith J, et al. (2021) Mitochondrial targeted meganuclease as a platform to eliminate mutant mtDNA in vivo. Nature Communications. 12: 3210
Smith J, Inglis RF. (2021) Evaluating kin and group selection as tools for quantitative analysis of microbial data. Proceedings. Biological Sciences. 288: 20201657
Baker B, Schaeffler B, Hirman J, et al. (2021) Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Endocrinology, Diabetes & Metabolism. 4: e00217
Smith TR, Janelidze M, Chakhava G, et al. (2021) Corrigendum to "Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study" [Clin Therapeut 42 (12) (2020) 2254-2265]. Clinical Therapeutics
Smith TR, Janelidze M, Chakhava G, et al. (2020) Eptinezumab for the Prevention of Episodic Migraine: Sustained Effect Through 1 Year of Treatment in the PROMISE-1 Study. Clinical Therapeutics
Dodick DW, Gottschalk C, Cady R, et al. (2020) Eptinezumab Demonstrated Efficacy in Sustained Prevention of Episodic and Chronic Migraine Beginning on Day 1 After Dosing. Headache
Davidson SC, Bohrer G, Gurarie E, et al. (2020) Ecological insights from three decades of animal movement tracking across a changing Arctic. Science (New York, N.Y.). 370: 712-715
Kannry J, Smith J, Mohan V, et al. (2020) Policy Statement on Clinical Informatics Fellowships and the Future of Informatics-Driven Medicine. Applied Clinical Informatics. 11: 710-713
See more...